Abstract
A newly-constructed antibody-like molecule containing the gp!20-binding domain of the receptor for human immunodeficiency virus blocks HIV-1 infection of T cells and monocytes. Its long plasma half-life, other antibody-like properties, and potential to block all HIV isolates, make it a good candidate for therapeutic use.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Curran, J. et al. Science 239, 610–616 (1988).
Hu, S.-L. et al. Nature 328, 721–723 (1987).
Berman, P. et al. Proc. natn. Acad. Sci. U.S.A. 85, 5200–5204 (1988).
Prince, A. et al. Proc. natn. Acad. Sci. U.S.A. 85, 6944–6948 (1988).
Weiss, R. et al. Nature 324, 572–575 (1986).
Mitsuya, H. & Broder, S. Nature 325, 773–778 (1987).
Smith, D. et al. Science 328, 1704–1707 (1987).
Sattentau, Q. & Weiss, R. Cell 52, 631–633 (1988).
Janeway, C. Nature 335, 208–210 (1988).
Dalgleish, A. et al. Nature 312, 763–767 (1984).
Klalzmann, D. et al. Nature 312, 767–768 (1984).
Maddon, P. et al. Cell 47, 333–348 (1986).
McDougal, J. et al. Science 231, 382–385 (1986).
Fisher, R. et al. Nature 331, 76–78 (1988).
Hussey, R. et al. Nature 331, 78–81 (1988).
Deen, K. et al. Nature 331, 82–84 (1988).
Traunecker, A., Luke, W. & Karjalainen, K. Nature 331, 84–86 (1988).
Berger, E., Fuerst, T. & Moss, B. Proc. natn. Acad. Sci. U.S.A. 85, 2357–2361 (1988).
Siliciano, R. et al. Cell 54, 561–575 (1988).
Doyle, C. & Strominger, J. Nature 330, 256–259 (1987).
Maddon, P. et al. Cell 42, 93–104 (1985).
Clark, S., Jefferies, W., Barclay, A., Gagnon, J. & Williams, A. Proc. natn. Acad. Sci. U.S.A. 84, 1649–1653 (1987).
Dorai, H. & Moore, G. J. Immun. 139, 4232–4241 (1987).
Nakamura, R., Speigelberg, H., Lee, S. & Wiegle, W. J. Immun. 100, 376–383 (1968).
Mordenti, J. J. Pharmaceut. Sci. 75, 1028–1040 (1986).
Burton, D. Molec. Immun. 22, 161–206 (1985).
Duncan, A. & Winter, G. Nature 332, 738–740 (1988).
Duncan, A., Woof, J., Partridge, L., Burton, D. & Winter, G. Nature 332, 563–564 (1988).
Leatherbarrow, R. & Dwek, R. Molec. Immun. 21, 321–327 (1984).
Feinstein, A., Richardson, N. & Taussig, M. J. Immun. Today 7, 169–174 (1986).
Gallo, R. et al. Science 224, 500–505 (1984).
Mitsuya, H. & Broder, S. Proc. natn. Acad. Sci. U.S.A. 83, 1911–1915 (1986).
Homsy, J., Tateno, M. & Levy, J. Lancet i, 1285–1286 (1988).
Takeda, A., Tuazon, C. & Ennis, F. Science 242, 580–583 (1988).
Gartner, S. et al. Science 233, 215–219 (1986).
Lane, H. & Fauci, A. A. Rev. Immun. 3, 477–500 (1985).
Harper, M., Marselle, L., Gallo, R. & Wong-Staal, F. Proc. natn. Acad. Sci. U.S.A. 83, 772–776 (1986).
Duesberg, P. Science 241, 514 (1988).
Lifson, J., Reyes, G., McGrath, M., Stein, B. & Engelman, E. Science 232, 1123–1127 (1986).
Sodroski, J., Goh, W., Rosen, C., Campbell, K. & Haseltine, W. Nature 322, 470–474 (1986).
Schneider, I., Kaaden, O., Copeland, T. D., Oroslan, S. & Hunsmann, G. J. gen Virol. 67, 2533–2539 (1986).
Lynette, G., Hartzman, R., Ledbetter, J. & June, C. Science 241, 573–576 (1988).
Kornfeld, H., Cruikshank, W., Pyle, S., Berman, J. & Center, D. Nature 335, 445–448 (1988).
Lyerly, H. Matthews, T., Langlois, A., Bolognesi, D. & Weinhold, K. Proc. natn. Acad. Sci. U.S.A. 84, 4601–4605 (1987).
Lanzavecchia, A., Roosneck, E., Gregory, T., Berman, P. & Abrignani, S. Nature 334, 530–532 (1988).
Sethi, K., Naher, H. & Stroehmann, I. Nature 335, 178–181 (1988).
Ellison, J. P., Berson, B. J. & Hood, L. E. Nucleic Acids Res. 10, 4071–4079 (1982).
Zoller, M. & Smith, M. Nucleic Acids Res. 10, 6487–6500 (1982).
Muesing, M., Smith, D. & Capon, D. Cell 48, 691–701 (1987).
Lasky, L. et al. Cell 50, 975–985 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Capon, D., Chamow, S., Mordenti, J. et al. Designing CD4 immunoadhesins for AIDS therapy. Nature 337, 525–531 (1989). https://doi.org/10.1038/337525a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/337525a0